摘要
双重金属粒子基于金和合金,由于电浆的协同协同特性和铁与氧化铁的惰性金成分和磁性,使科学家对于它的研究兴趣越来越大,使这种混合的纳米材料成像稳定,有治疗和分析的应用。在这个简短的综述中,我们强调了金材质的纳米材料,有磁性成像的可能,焦点在于金-铁混合系统作为T2重量潜力和金材质造影剂。
关键词: 双重金属纳米粒,金-铁合金纳米粒,核磁共振成像,氟化金纳米粒,多重模型造影剂。
Current Medicinal Chemistry
Title:Recent Advances in the Synthesis and Applications of Multimodal Gold-Iron Nanoparticles
Volume: 24 Issue: 5
关键词: 双重金属纳米粒,金-铁合金纳米粒,核磁共振成像,氟化金纳米粒,多重模型造影剂。
摘要: Bimetallic particles based on gold and iron have been gathering increasing interest in biomedical applications because of the synergic combination of the plasmonic features of the inert gold component with the magnetic properties of the iron or iron oxide fraction, that makes these hybrid nanomaterials suitable for imaging, therapeutic and analytical applications. In this minireview, we emphasize gold-based nanomaterials with potential for Magnetic Resonance Imaging, focusing on Au-Fe hybrid systems as potential T2-weighted, goldbased contrast agents.
Export Options
About this article
Cite this article as:
Recent Advances in the Synthesis and Applications of Multimodal Gold-Iron Nanoparticles, Current Medicinal Chemistry 2017; 24 (5) . https://dx.doi.org/10.2174/0929867323666160829111531
DOI https://dx.doi.org/10.2174/0929867323666160829111531 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
Current Drug Targets Postoperative Radiotherapy After Radical Prostatectomy: Adjuvant or Salvage?
Current Cancer Therapy Reviews Phytochemicals for Breast Cancer Therapy: Current Status and Future Implications
Current Cancer Drug Targets Laminin-332-Integrin Interaction: A Target For Cancer Therapy?
Current Medicinal Chemistry Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry (Iso)Flav(an)ones, Chalcones, Catechins, and Theaflavins as Anticarcinogens: Mechanisms, Anti-Multidrug Resistance and QSAR Studies
Current Medicinal Chemistry Improving Cancer Therapeutics by Molecular Profiling
Current Drug Metabolism Metallic Colloid Nanotechnology, Applications in Diagnosis and Therapeutics
Current Pharmaceutical Design β3-Adrenergic Receptors: Really Relevant Targets for Anti-Obesity Drugs?
Current Medicinal Chemistry - Central Nervous System Agents Management of Vaginal Cancer
Reviews on Recent Clinical Trials Cerebral Angiogenesis and Expression of Angiogenic Factors in Aging Rats after Exercise
Current Neurovascular Research Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry Self-Assembling Peptide Nanofibrous Scaffolds for Tissue Engineering: Novel Approaches and Strategies for Effective Functional Regeneration
Current Protein & Peptide Science TRP Channels as Therapeutic Targets in Kidney Disease and Hypertension
Current Topics in Medicinal Chemistry Recent Advances in Azo Dye Degrading Enzyme Research
Current Protein & Peptide Science Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level
Medicinal Chemistry Hypoxia Responsive Drug Delivery Systems in Tumor Therapy
Current Pharmaceutical Design How Recent Patents Have Changed our Clinical Approach in Cardio-Thoracic Surgery
Recent Patents on Regenerative Medicine NONO-TFE3 Fusion Promotes Aerobic Glycolysis and Angiogenesis by Targeting <i>HIF1A</i> in <i>NONO-TFE3</i> Translocation Renal Cell Carcinoma
Current Cancer Drug Targets Label Free Ultrasmall Fluoromagnetic Ferrite-clusters for Targeted Cancer Imaging and Drug Delivery
Current Drug Delivery